Press Review
Press Review
AYOXXA launches LUNARIS Protein Analysis System in Asia
Founded in 2010 as a spin-off of the National University of Singapore, AYOXXA Biosystems is one of the success stories of Singapore’s Biotech start-up community. It has since grown into a global biotech company headquartered in Cologne, Germany, and it remains focused on the development and commercialization of its proprietary technology for advanced protein analysis, LUNARIS™. AYOXXA Living Health Technologies Pte. Ltd., a Singapore-based subsidiary of AYOXXA, is collaborating closely with the Singapore Eye Research Institute (SERI), the research arm of Singapore National Eye Center (SNEC), to develop and market the LUNARIS™ platform in Asia.